LigaTrap™ Technologies, LLC
Stefano Menegatti has extensive work experience as a Chief Technology Officer and Scientific Advisor at LigaTrap™ Technologies, LLC since February 2022. Prior to that, they worked as an Associate Professor and Assistant Professor at North Carolina State University starting from August 2015.
Stefano Menegatti began their education at Università di Bologna, where they received their Bachelor's Degree in Chemical Engineering from 2003 to 2006. Following this, they pursued their academic career at North Carolina State University from 2009 to 2013, where they obtained their Doctor of Philosophy (Ph.D.) in Chemical and Biomolecular Engineering. Lastly, Stefano attended UC Santa Barbara from 2013 to 2015, specializing in Chemical Engineering.
This person is not in any teams
LigaTrap™ Technologies, LLC
LigaTrap has developed a novel, patented portfolio of affinity ligands for the purification of monoclonal and polyclonal immunoglobulins from various species. In addition to species-specific ligands, advantages include the ability to elute bound antibodies at a milder pH (pH 4.0) than proteins A and G (pH ≤ 3.0), thus reducing the potential forprecipitation and inactivation of pH sensitive antibodies.Their research lab is in Raleigh, NC and their corporate office is in Baton Rouge, LA, their goal is to generate high purity antibodies using ligands superior to those currently available in the marketplace. Through extensive side-by-side testing with purification products that are currently on the market, beta testing from independent third parties, market research by industry experts, and feedback from leading think tanks within the sector, the technology is proven and deemed superior to those available in specific niche uses.